Clinical trials recruiting for Fatty Liver

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Blood Collection Biorepository for Liver Disease Research
  NCT03025074 · Phase: Not specified · Ages: 7 Years and older · Sex: All (male and female) · 2 locations
• Cardiac Dysfunction in Patients with Fatty Liver Disease
  NCT06386094 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
  NCT07238985 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
  NCT04873258 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Early Tracking of Childhood Health Determinants (ETCHED) Study
  NCT03481829 · Phase: Not specified · Ages: 1 Day to 99 Years · Sex: All (male and female) · 1 location
• Effect of CoQ10 on the Outcome of MAFLD Patients
  NCT05984745 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
  NCT07646197 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 70 Years · Sex: All (male and female) · 1 location
• Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
  NCT03851627 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
  NCT07242222 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
  NCT06661655 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations
• Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
  NCT07068191 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Intermittent Fasting for NAFLD in Adults
  NCT04899102 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)
  NCT07737340 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter
  NCT06203548 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
  NCT04371042 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
  NCT06989723 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
  NCT06599918 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Fatty Liver often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Fatty Liver trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.